The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Sep 2016 10:42

RNS Number : 6794K
Premaitha Health PLC
23 September 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Premaitha Health plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

ü

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Life Technologies Limited, a company incorporated in Scotland with company number SC083107

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

22 September 2016

6. Date on which issuer notified:

23 September 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Below 9% and through 9%, 10%, 11%, 12% and 13%

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Warrants

24.6p

11 December 2023

Exercisable up to 11 December 2023

 

20,325,204

Nominal

Delta

8.9% (based on current share capital) and 7.07% (based on so-enlarged share capital)

 

Warrants

11.7p

11 December 2023

Exercisable up to 11 December 2023

 

17,094,018

Nominal

7.5% (based on current share capital) and 5.95% (based on so-enlarged share capital)

Delta

 

 

 

 

 

 

 

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

37,419,222

16.4% (based on current share capital) and 13.03% (based on so-enlarged share capital).

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Life Technologies Limited is a controlled undertaking of Thermo Fisher Scientific Inc. a company incorporated in the United States of America.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Ted Fong

15. Contact telephone number:

001 (650) 244-1616

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOSKRNRAKURR
Date   Source Headline
15th Apr 201412:30 pmRNSSuspension
9th Apr 20141:55 pmRNSChange of Advisers and Registered Office
26th Mar 20143:16 pmRNSCompletion of VEC Transfer
21st Mar 20147:00 amRNSResignation of Dr. Robert Dean
19th Mar 20143:09 pmRNSReplacement announcement: Grant of options
19th Mar 201412:25 pmRNSGrant of options
7th Mar 20141:43 pmRNSHolding(s) in Company
7th Mar 20141:39 pmRNSHolding(s) in Company
27th Jan 20142:00 pmRNSResult of General Meeting
24th Jan 20143:22 pmRNSResult of Open Offer
7th Jan 20147:00 amRNSPlacing, Open Offer & Notice of General Meeting
4th Dec 20134:13 pmRNSResult of General Meeting
2nd Dec 20138:00 amRNSHalf Yearly Report
18th Nov 20131:30 pmRNSNotice of General Meeting & Proposed Board Changes
29th Oct 20133:31 pmRNSResult of AGM
29th Oct 20137:00 amRNSRestructure Proposals
30th Sep 20137:00 amRNSFinal Results
29th Aug 20139:00 amRNSNotice of AGM
19th Jun 20133:09 pmRNSExercise of Warrants & TVR
8th May 20137:00 amRNSContract Win
29th Apr 20137:00 amRNSBusiness & Technical Collaboration with CGG
16th Apr 20137:00 amRNSChange of Adviser
12th Apr 20137:00 amRNSChevron - precision subsurface mapping contract
8th Feb 20133:01 pmRNSPlacing of £1.4 million
7th Jan 20137:00 amRNSFiling of QuantumRD patents in nine countries
2nd Jan 20138:36 amRNSChevron Expands ViaLogy Contract
31st Dec 20127:00 amRNSHalf Yearly Report
19th Dec 20127:00 amRNSCEO Overview
21st Nov 20127:00 amRNSMove into Shale Oil Development
16th Nov 20127:00 amRNSNorth Sea Project Underway
1st Oct 20127:00 amRNSQuantumRD Services in China
20th Sep 20127:00 amRNSPresentation at Singapore Conference
23rd Jul 20121:50 pmRNSResult of AGM
29th Jun 20127:00 amRNSFinal Results
15th Jun 201211:25 amRNSResult of General Meeting
23rd May 20127:00 amRNSNotice of General Meeting
21st May 20127:00 amRNSPlacing
11th May 20129:30 amRNSIssue of Equity - Options Exercise
10th May 20127:00 amRNSBusiness Update
2nd May 201212:24 pmRNSContract Award
23rd Apr 20127:00 amRNSContract win
16th Apr 20127:00 amRNSSuccessful Texas Oil Well Drilled
12th Apr 20127:00 amRNSContract Win
14th Mar 20127:00 amRNSQuantumRD demonstration to Chevron
18th Jan 20127:00 amRNSPlacing and TVR
3rd Jan 20127:00 amRNSBusiness Update
30th Dec 20117:00 amRNSInterim Report & Accounts
28th Oct 201112:36 pmRNSResult of AGM
11th Oct 20113:28 pmRNSPlacing & TVR
30th Sep 20117:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.